Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies.

Autor: Zhu, Mojun¹ (AUTHOR) xie.hao@mayo.edu, Taylor, William R.² (AUTHOR) gonser.anna@mayo.edu, Mahoney, Douglas W.³ (AUTHOR), Then, Sara S.² (AUTHOR) doering.karen@mayo.edu, Berger, Calise K.² (AUTHOR) foote.patrick@mayo.edu, Burger, Kelli N.³ (AUTHOR), Gonser, Anna M.² (AUTHOR), Doering, Karen A.² (AUTHOR), Xie, Hao¹ (AUTHOR), Foote, Patrick H.² (AUTHOR), Kaiser, Michael W.⁴ (AUTHOR) mkaiser@exactsciences.com, Allawi, Hatim T.⁴ (AUTHOR), Hubbard, Joleen M.⁵ (AUTHOR), Kisiel, John B.² (AUTHOR) kisiel.john@mayo.edu

Publikováno v: Cancers. Dec2023, Vol. 15 Issue 24, p5778. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An open-label clinical trial of RP2 and RP3 oncolytic immunotherapy in combination with atezolizumab plus bevacizumab for the treatment of patients with advanced colorectal carcinoma.

Autor: Lenz, Heinz-Josef, Somasundaram, Ashwin, Lee, Michael Sangmin, Sohal, Davendra, Safyan, Rachael A, Zhu, Mojun, Jones, Jeremy Clifton, Bhansali, Aditya, Kalwar, Roza, Cho, May, Grothey, Axel

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS228-TPS228, 235p

Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.

Autor: Jazieh, Khalid, Tsai, Jill, Zhu, Mojun, Xie, Hao

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p170-170, 235p